MedTrace Logo

Randomized Study to Compare the Bioavailability of Two Clobetasol Propionate 0.05% Topical Foams

NCT00803439 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2021-10-15

No results posted yet for this study

Summary

The purpose of this study was to compare the relative vasoconstrictive effects of test and reference Clobetasol Propionate 0.05% Topical Foam in healthy, female subjects.

Conditions

  • Healthy

Interventions

DRUG

Clobetasol Propionate 0.05% Foam-Reference Product

Small amount applied and evaluated over the course of two days

DRUG

Clobetasol Propionate 0.05% Foam-Test product

Small amount applied and evaluated over the course of two days

Sponsors & Collaborators

  • Padagis LLC

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2005-04-30
Completion
2005-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00803439 on ClinicalTrials.gov